Quock Raymond M, Vaughn Linda K
Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, P.O. Box 646534, Pullman, WA 99164, USA.
Life Sci. 2005 Oct 7;77(21):2603-10. doi: 10.1016/j.lfs.2005.04.023.
The antagonism of some effects of inhalation general anesthetic agents by naloxone suggests that there may be an opioid component to anesthetic action. There is evidence that this opioid action component is due to neuronal release of endogenous opioid peptides. The strongest evidence is provided by studies that monitor changes in the concentration of opioid peptides in the perfused brain following inhalation of the anesthetic. Indirect or circumstantial evidence also comes from studies of anesthetic effects on regional brain levels of opioid peptides, antagonism of selected anesthetic effects by antisera to opioid peptides and anesthetic-induced changes radioligand binding to opioid receptors. It is likely that some inhalation general anesthetics (e.g., nitrous oxide) can induce neuronal release of opioid peptides and that this may contribute to certain components of general anesthesia (e.g., analgesia). More definitive studies utilizing in vivo microdialysis or autoradiography in selected areas of the brain during induction and successive states of general anesthesia have yet to be conducted.
纳洛酮对吸入性全身麻醉药某些作用的拮抗作用表明,麻醉作用中可能存在阿片样物质成分。有证据表明,这种阿片样物质作用成分是由于内源性阿片肽的神经元释放。最有力的证据来自于监测吸入麻醉药后灌注脑内阿片肽浓度变化的研究。间接或旁证也来自于对麻醉药对脑内阿片肽区域水平的影响、抗阿片肽抗血清对特定麻醉作用的拮抗作用以及麻醉诱导的放射性配体与阿片受体结合变化的研究。某些吸入性全身麻醉药(如氧化亚氮)可能诱导阿片肽的神经元释放,这可能有助于全身麻醉的某些成分(如镇痛)。尚未进行更确切的研究,即在全身麻醉诱导期和连续状态下,利用体内微透析或放射自显影技术在脑的选定区域进行研究。